May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
In Vivo Characterization of the Murine Keratocan (mKera) Promoter
Author Affiliations & Notes
  • J. Ouyang
    Physiology/Biophysics, University of Miami, Miami, FL
  • E.C. Carlson
    Ophthalmology, Cole Eye Institute/ Cleveland Clinic Foundation, Cleveland, OH
  • V.L. Perez
    Ophthalmology, Cole Eye Institute/ Cleveland Clinic Foundation, Cleveland, OH
  • T. Chikama
    Ophthalmology, University of Cincinnati, Cincinnati, OH
  • W.W. Kao
    Ophthalmology, University of Cincinnati, Cincinnati, OH
  • H. Yi
    Ophthalmology, Bascom Palmer Eye Institute/University of Miami, Miami, FL
  • L.–K. Yeh
    Ophthalmology, Bascom Palmer Eye Institute/University of Miami, Miami, FL
  • M.E. Fini
    Ophthalmology, Bascom Palmer Eye Institute/University of Miami, Miami, FL
  • C.–Y. Liu
    Ophthalmology, Bascom Palmer Eye Institute/University of Miami, Miami, FL
  • Footnotes
    Commercial Relationships  J. Ouyang, None; E.C. Carlson, None; V.L. Perez, None; T. Chikama, None; W.W. Kao, None; H. Yi, None; L. Yeh, None; M.E. Fini, None; C. Liu, None.
  • Footnotes
    Support  NIH EY12486,EY 11845, EY13755, K08EY014912–01, RPB,and Knights Templar Foundation
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4714. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Ouyang, E.C. Carlson, V.L. Perez, T. Chikama, W.W. Kao, H. Yi, L.–K. Yeh, M.E. Fini, C.–Y. Liu; In Vivo Characterization of the Murine Keratocan (mKera) Promoter . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4714.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To identify the elements of the mKerapr3.2–bpA promoter responsible for cornea–specific gene expression using deletion mutant analysis in vivo. Methods: The entire intron 1 sequence of mKera was inserted into mKerapr3.2–EGFP to generate mKerapr3.2–int–EGFP–bpA. A series of deletion mutant mKera promoters were generated (–2.8kb, –2.0 kb, –1.1 kb, –0.8 kb, and –0.3 kb) by restriction enzyme digestion and re–ligation into the mKerapr3.2–int–EGFP–bpA. Deletion mKera promoter mutants and control plasmids were delivered in vivo to murine corneal stroma and conjunctiva by intrastromal and conjunctival injections. In vivo expression was determined by measuring EGFP using a stereomicroscope at different time points. After 48 hours eye were enucleated and analyzed further using fluorescent stereo and confocal microscopies. Results: In vivo transfection of corneas with the mKerapr3.2–EGFP–bpA construct resulted in poor EGFP reporter gene expression in corneal stroma cells. In contrast, the mKerapr3.2–int–EGFP–bpA promoter resulted in stronger in vivo expression, suggesting that intron 1 contains a putative enhancer or is critical for proper processing of the transcript. In vivo deletion mutant analysis showed that deletion from –3.2 kb to –2.8 kb reduced promoter activity by ∼ 60% and further deletion to –1.1 kb resulted in the loss of promoter activity. However, deletions to –0.8 kb and –0.3 kb restored the promoter activity back to 40 % and 90 %, respectively, as compared to that of the –3.2 kb promoter. All of the mKera promoters tested showed cornea–specific EGFP expression. Conclusions: These results show the ability of in vivo promoter analysis to identify cis–regulatory elements in mKera between –1.1 and –0.8 kb which serve as silencers that can be overcome by enhancers between –3.2 kb to –1.1 kb. Furthermore, we have identified mKera intron 1 as being crucial for its promoter activity in corneal stromal cells and the –0.3 kb mKera promoter region being sufficient to drive cornea–specific expression.

Keywords: cornea: basic science • gene/expression • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×